No Data
No Data
Express News | Verrica Pharmaceuticals - Waiver Includes Requirements That There Be No 'going Concern' Qualification for 2024 and Q1 2025
Express News | Verrica Pharmaceuticals Inc - Enters Waiver to Credit Agreement
Trump Rolls Back Effort to Lower Medicare, Medicaid Drug Costs
Verrica Pharmaceuticals Announces Presentation of Three Posters, Data on VP-315
Express News | Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of Vp-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
Unlock the Full List